144 related articles for article (PubMed ID: 37501009)
1. Total Superior Mesenteric Artery Nerve Plexus Preservation During Pancreaticoduodenectomy for Pancreatic Cancer.
Miyazaki Y; Oda T; Shimomura O; Hashimoto S; Doi M; Takahashi K; Owada Y; Furuya K; Ogawa K; Ohara Y; Akashi Y; Enomoto T
World J Surg; 2023 Nov; 47(11):2816-2824. PubMed ID: 37501009
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcome of Patients with Postoperative Refractory Diarrhea After Tailored Nerve Plexus Dissection Around the Major Visceral Arteries During Pancreatoduodenectomy for Pancreatic Cancer.
Kuroki N; Ono Y; Sato T; Inoue Y; Oba A; Ito H; Mise Y; Saiura A; Takahashi Y
World J Surg; 2022 May; 46(5):1172-1182. PubMed ID: 35119513
[TBL] [Abstract][Full Text] [Related]
3. Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer.
Nagakawa Y; Yi SQ; Takishita C; Sahara Y; Osakabe H; Kiya Y; Yamaguchi H; Miwa Y; Sato I; Tsuchida A
J Hepatobiliary Pancreat Sci; 2020 Jun; 27(6):342-351. PubMed ID: 32048456
[TBL] [Abstract][Full Text] [Related]
4. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on the clinical therapeutic effects of arterial first approach pancreatoduodenectomy in the treatment of borderline resectable pancreatic adenocarcinoma].
Jin G; Zheng KL; Guo SW; Shao Z; Liu C; Shi XH; Liu RD; Bai SJ; Jiang H; Bian Y; Hu XG
Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):909-915. PubMed ID: 29224265
[No Abstract] [Full Text] [Related]
6. Mesenteric approach during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Shimokawa T; Nakao A; Yamaue H
Ann Gastroenterol Surg; 2017 Sep; 1(3):208-218. PubMed ID: 29863125
[TBL] [Abstract][Full Text] [Related]
7. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
[TBL] [Abstract][Full Text] [Related]
8. Pancreaticoduodenectomy with right-oblique posterior dissection of superior mesenteric nerve plexus is logical procedure for pancreatic cancer with extrapancreatic nerve plexus invasion.
Nagakawa Y; Hosokawa Y; Osakabe H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasahara K; Kazuhiko K; Saito K; Tsuchida A
Hepatogastroenterology; 2014; 61(136):2371-6. PubMed ID: 25699385
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE technique for resectable pancreatic ductal adenocarcinoma.
Hang HX; Cai ZH; Yang YF; Fu X; Qiu YD; Cheng H
World J Gastrointest Surg; 2024 Mar; 16(3):689-699. PubMed ID: 38577093
[TBL] [Abstract][Full Text] [Related]
10. Strategies in the Management of Pancreatic Ductal Adenocarcinoma Involving Aberrant Right Hepatic Artery Arising From the Superior Mesenteric Artery.
Maharjan DK; Ghimire R; Limbu Y; Regmee S; Pahari R; Shrestha SK; Thapa PB
Cureus; 2022 Oct; 14(10):e30781. PubMed ID: 36320800
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized phase II trial of prophylactic right-half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer.
Yamada S; Satoi S; Takami H; Yamamoto T; Yoshioka I; Sonohara F; Yamaki S; Shibuya K; Hayashi M; Hashimoto D; Ando M; Murotani K; Sekimoto M; Kodera Y; Fujii T
Ann Gastroenterol Surg; 2021 Jan; 5(1):111-118. PubMed ID: 33532687
[TBL] [Abstract][Full Text] [Related]
12. En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.
Kitagawa H; Tajima H; Nakagawara H; Makino I; Miyashita T; Shoji M; Nakanuma S; Hayashi N; Takamura H; Ohta T; Ohtake H
Mol Clin Oncol; 2014 May; 2(3):369-374. PubMed ID: 24772302
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival and Recurrence in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Upfront Surgery.
Lee B; Yoon YS; Kang M; Park Y; Lee E; Jo Y; Lee JS; Lee HW; Cho JY; Han HS
Ann Surg Oncol; 2023 Jun; 30(6):3444-3454. PubMed ID: 36695994
[TBL] [Abstract][Full Text] [Related]
14. Pancreaticoduodenectomy with celiac artery resection (PD-CAR) for unresctable locally advanced pancreatic ductal adenocarcinoma.
Kimura K; Amano R; Tauchi J; Nishio K; Ohira G; Shinkawa H; Tanaka S; Yamamoto A; Motomura H; Ishizawa T
Langenbecks Arch Surg; 2023 May; 408(1):174. PubMed ID: 37140679
[TBL] [Abstract][Full Text] [Related]
15. Potentiality of dissection of the lymph nodes with preservation of the nerve plexus around the superior mesenteric artery.
Kawabata A; Hamanaka Y; Suzuki T
Hepatogastroenterology; 1998; 45(19):236-41. PubMed ID: 9496520
[TBL] [Abstract][Full Text] [Related]
16. Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.
Hayasaki A; Isaji S; Kishiwada M; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Mizuno S; Usui M; Sakurai H
Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29510561
[No Abstract] [Full Text] [Related]
17. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Involving the Superior Mesenteric Artery].
Matsukawa H; Shiozaki S; Satoh D; Yoshida K; Araki H; Idani H; Ojima Y; Harano M; Kanazawa T; Tokumoto N; Choda Y; Ishida M; Miyoshi H; Okajima M; Ninomiya M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1485-7. PubMed ID: 26805071
[TBL] [Abstract][Full Text] [Related]
19. Left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma.
Aimoto T; Mizutani S; Kawano Y; Matsushita A; Yamashita N; Suzuki H; Uchida E
J Nippon Med Sch; 2013; 80(6):438-45. PubMed ID: 24419715
[TBL] [Abstract][Full Text] [Related]
20. Complete Lymphadenectomy Around the Entire Superior Mesenteric Artery Improves Survival in Artery-First Approach Pancreatoduodenectomy for T3 Pancreatic Ductal Adenocarcinoma.
Kobayashi S; Otsubo T; Nakano H; Koizumi S; Nakahara K
World J Surg; 2021 Mar; 45(3):857-864. PubMed ID: 33174091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
